Medite Cancer Diagnostics Stock Market Value
| MDIT Stock | USD 0.0001 0.00 0.00% |
| Symbol | Medite |
Medite Cancer 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medite Cancer's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medite Cancer.
| 11/25/2025 |
| 12/25/2025 |
If you would invest 0.00 in Medite Cancer on November 25, 2025 and sell it all today you would earn a total of 0.00 from holding Medite Cancer Diagnostics or generate 0.0% return on investment in Medite Cancer over 30 days. Medite Cancer Diagnostics, Inc. operates as a medical technology company More
Medite Cancer Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medite Cancer's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medite Cancer Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 98.0 |
Medite Cancer Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medite Cancer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medite Cancer's standard deviation. In reality, there are many statistical measures that can use Medite Cancer historical prices to predict the future Medite Cancer's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.57) | |||
| Total Risk Alpha | (2.50) | |||
| Treynor Ratio | (1.11) |
Medite Cancer Diagnostics Backtested Returns
We have found sixteen technical indicators for Medite Cancer, which you can use to evaluate the volatility of the firm. Please verify Medite Cancer's Risk Adjusted Performance of (0.08), mean deviation of 2.92, and Standard Deviation of 12.06 to check out if the risk estimate we provide is consistent with the expected return of 0.0%. The company secures a Beta (Market Risk) of 1.34, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medite Cancer will likely underperform. Medite Cancer Diagnostics right now secures a risk of 0.0%. Please verify Medite Cancer Diagnostics mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Medite Cancer Diagnostics will be following its current price movements.
Auto-correlation | 0.00 |
No correlation between past and present
Medite Cancer Diagnostics has no correlation between past and present. Overlapping area represents the amount of predictability between Medite Cancer time series from 25th of November 2025 to 10th of December 2025 and 10th of December 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medite Cancer Diagnostics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Medite Cancer price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Medite Cancer Diagnostics lagged returns against current returns
Autocorrelation, which is Medite Cancer pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medite Cancer's pink sheet expected returns. We can calculate the autocorrelation of Medite Cancer returns to help us make a trade decision. For example, suppose you find that Medite Cancer has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medite Cancer regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medite Cancer pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medite Cancer pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medite Cancer pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Medite Cancer Lagged Returns
When evaluating Medite Cancer's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medite Cancer pink sheet have on its future price. Medite Cancer autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medite Cancer autocorrelation shows the relationship between Medite Cancer pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Medite Cancer Diagnostics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medite Pink Sheet Analysis
When running Medite Cancer's price analysis, check to measure Medite Cancer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medite Cancer is operating at the current time. Most of Medite Cancer's value examination focuses on studying past and present price action to predict the probability of Medite Cancer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medite Cancer's price. Additionally, you may evaluate how the addition of Medite Cancer to your portfolios can decrease your overall portfolio volatility.